Perspectives on the COVID-19 pandemic impact on cardio-oncology: results from the COVID-19 International Collaborative Network survey
Abstract Background Re-allocation of resources during the COVID-19 pandemic has resulted in delays in care delivery to patients with cardiovascular disease and cancer. The ability of health care providers to provide optimal care in this setting has not been formally evaluated. Objectives To assess t...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-11-01
|
Series: | Cardio-Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40959-020-00085-5 |
id |
doaj-3d53cbbe9da6429cb54c6ff34e368ba9 |
---|---|
record_format |
Article |
spelling |
doaj-3d53cbbe9da6429cb54c6ff34e368ba92020-11-29T12:09:36ZengBMCCardio-Oncology2057-38042020-11-016111310.1186/s40959-020-00085-5Perspectives on the COVID-19 pandemic impact on cardio-oncology: results from the COVID-19 International Collaborative Network surveyDiego Sadler0Jeanne M. DeCara1Joerg Herrmann2Anita Arnold3Arjun K. Ghosh4Husam Abdel-Qadir5Eric H. Yang6Sebastian Szmit7Nausheen Akhter8Monika Leja9Carolina Maria Pinto Domingues Carvalho Silva10Jayant Raikhelkar11Sherry-Ann Brown12Susan Dent13Rupal O’Quinn14Franck Thuny15Rohit Moudgil16Luis E. Raez17Tochukwu Okwuosa18Andres Daniele19Brenton Bauer20Lavanya Kondapalli21Roohi Ismail-Khan22Jorge Lax23Anne Blaes24Zeina Nahleh25Leah Elson26Lauren A. Baldassarre27Vlad Zaha28Vijay Rao29Daniel Sierra Lara30Kerry Skurka31on behalf of the Cardio-Oncology International Collaborative NetworkHeart and Vascular Center, Cleveland Clinic FloridaUniversity of ChicagoMayo ClinicLee HealthBarts Heart Centre, St Bartholomew’s Hospital, and University College London’s HospitalWomen’s College Hospital and Peter Munk Cardiac Centre, University of TorontoUCLA Cardio-Oncology Program, University of CaliforniaCentre of Postgraduate Medical educationNorthwestern Feinerg School of MedicineUniversity of MichiganUniversity of Sao PauloColumbia University Irving Medical CenterMedical College of WisconsinDuke UniversityUniversity of PennsylvaniaAix-Marseille UniversityCleveland ClinicMemorial Health Care, Florida International UniversityRush University Medical CenterRoffo InstituteTorrance Memorial Medical CenterUniversity of ColoradoH. Lee Moffitt Cancer CenterHospital Cosme ArgerichUniversity of MinnesotaHeart and Vascular Center, Cleveland Clinic FloridaHeart and Vascular Center, Cleveland Clinic FloridaYale School of MedicineUT SouthwesternFranciscan HealthInstituto Nacional de CardiologiaFranciscan HealthAbstract Background Re-allocation of resources during the COVID-19 pandemic has resulted in delays in care delivery to patients with cardiovascular disease and cancer. The ability of health care providers to provide optimal care in this setting has not been formally evaluated. Objectives To assess the impact of COVID-19 resource re-allocation on scheduling, testing, elective procedures, telemedicine access, use of new COVID-19 therapies, and providers’ opinions on healthcare policies among oncology and cardiology practitioners. Methods An electronic survey was conducted by a cardio-oncology collaborative network through regional and state chapters of the American College of Cardiology, American Society of Clinical Oncology, and the International Cardio-Oncology Society. Descriptive statistics were reported by frequency and proportion for analyses, and stratified categorically by geographic region and specialty. Results One thousand four hundred fifteen providers (43 countries) participated: 986 cardiologists, 306 oncologists, and 118 trainees/internal medicine. 63% (195/306) of oncologists vs 92% (896/976) of cardiologists reported cancellations of treatments/elective procedures (p = 0.01). 46% (442/970) of cardiologists and 25% (76/303) of oncologists modified the scope of their practice (p = < 0.001). Academic physicians (74.5%) felt better supplied with personal protective equipment (PPE) vs non-academic (74.5% vs 67.2%; p = 0.018). Telemedicine was less common in Europe 81% (74/91), and Latin America 64% (101/158), than the United States, 88% (950/1097) (p = < 0.001). 95% of all groups supported more active leadership from medical professional societies. Conclusions These results support initiatives to promote expanded coverage for telemedicine, increased access to PPE, better testing availability and involvement of medical professional societies to help with preparedness for future health care crisis.https://doi.org/10.1186/s40959-020-00085-5COVID-19Health policyGlobal HealthCardio oncology |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Diego Sadler Jeanne M. DeCara Joerg Herrmann Anita Arnold Arjun K. Ghosh Husam Abdel-Qadir Eric H. Yang Sebastian Szmit Nausheen Akhter Monika Leja Carolina Maria Pinto Domingues Carvalho Silva Jayant Raikhelkar Sherry-Ann Brown Susan Dent Rupal O’Quinn Franck Thuny Rohit Moudgil Luis E. Raez Tochukwu Okwuosa Andres Daniele Brenton Bauer Lavanya Kondapalli Roohi Ismail-Khan Jorge Lax Anne Blaes Zeina Nahleh Leah Elson Lauren A. Baldassarre Vlad Zaha Vijay Rao Daniel Sierra Lara Kerry Skurka on behalf of the Cardio-Oncology International Collaborative Network |
spellingShingle |
Diego Sadler Jeanne M. DeCara Joerg Herrmann Anita Arnold Arjun K. Ghosh Husam Abdel-Qadir Eric H. Yang Sebastian Szmit Nausheen Akhter Monika Leja Carolina Maria Pinto Domingues Carvalho Silva Jayant Raikhelkar Sherry-Ann Brown Susan Dent Rupal O’Quinn Franck Thuny Rohit Moudgil Luis E. Raez Tochukwu Okwuosa Andres Daniele Brenton Bauer Lavanya Kondapalli Roohi Ismail-Khan Jorge Lax Anne Blaes Zeina Nahleh Leah Elson Lauren A. Baldassarre Vlad Zaha Vijay Rao Daniel Sierra Lara Kerry Skurka on behalf of the Cardio-Oncology International Collaborative Network Perspectives on the COVID-19 pandemic impact on cardio-oncology: results from the COVID-19 International Collaborative Network survey Cardio-Oncology COVID-19 Health policy Global Health Cardio oncology |
author_facet |
Diego Sadler Jeanne M. DeCara Joerg Herrmann Anita Arnold Arjun K. Ghosh Husam Abdel-Qadir Eric H. Yang Sebastian Szmit Nausheen Akhter Monika Leja Carolina Maria Pinto Domingues Carvalho Silva Jayant Raikhelkar Sherry-Ann Brown Susan Dent Rupal O’Quinn Franck Thuny Rohit Moudgil Luis E. Raez Tochukwu Okwuosa Andres Daniele Brenton Bauer Lavanya Kondapalli Roohi Ismail-Khan Jorge Lax Anne Blaes Zeina Nahleh Leah Elson Lauren A. Baldassarre Vlad Zaha Vijay Rao Daniel Sierra Lara Kerry Skurka on behalf of the Cardio-Oncology International Collaborative Network |
author_sort |
Diego Sadler |
title |
Perspectives on the COVID-19 pandemic impact on cardio-oncology: results from the COVID-19 International Collaborative Network survey |
title_short |
Perspectives on the COVID-19 pandemic impact on cardio-oncology: results from the COVID-19 International Collaborative Network survey |
title_full |
Perspectives on the COVID-19 pandemic impact on cardio-oncology: results from the COVID-19 International Collaborative Network survey |
title_fullStr |
Perspectives on the COVID-19 pandemic impact on cardio-oncology: results from the COVID-19 International Collaborative Network survey |
title_full_unstemmed |
Perspectives on the COVID-19 pandemic impact on cardio-oncology: results from the COVID-19 International Collaborative Network survey |
title_sort |
perspectives on the covid-19 pandemic impact on cardio-oncology: results from the covid-19 international collaborative network survey |
publisher |
BMC |
series |
Cardio-Oncology |
issn |
2057-3804 |
publishDate |
2020-11-01 |
description |
Abstract Background Re-allocation of resources during the COVID-19 pandemic has resulted in delays in care delivery to patients with cardiovascular disease and cancer. The ability of health care providers to provide optimal care in this setting has not been formally evaluated. Objectives To assess the impact of COVID-19 resource re-allocation on scheduling, testing, elective procedures, telemedicine access, use of new COVID-19 therapies, and providers’ opinions on healthcare policies among oncology and cardiology practitioners. Methods An electronic survey was conducted by a cardio-oncology collaborative network through regional and state chapters of the American College of Cardiology, American Society of Clinical Oncology, and the International Cardio-Oncology Society. Descriptive statistics were reported by frequency and proportion for analyses, and stratified categorically by geographic region and specialty. Results One thousand four hundred fifteen providers (43 countries) participated: 986 cardiologists, 306 oncologists, and 118 trainees/internal medicine. 63% (195/306) of oncologists vs 92% (896/976) of cardiologists reported cancellations of treatments/elective procedures (p = 0.01). 46% (442/970) of cardiologists and 25% (76/303) of oncologists modified the scope of their practice (p = < 0.001). Academic physicians (74.5%) felt better supplied with personal protective equipment (PPE) vs non-academic (74.5% vs 67.2%; p = 0.018). Telemedicine was less common in Europe 81% (74/91), and Latin America 64% (101/158), than the United States, 88% (950/1097) (p = < 0.001). 95% of all groups supported more active leadership from medical professional societies. Conclusions These results support initiatives to promote expanded coverage for telemedicine, increased access to PPE, better testing availability and involvement of medical professional societies to help with preparedness for future health care crisis. |
topic |
COVID-19 Health policy Global Health Cardio oncology |
url |
https://doi.org/10.1186/s40959-020-00085-5 |
work_keys_str_mv |
AT diegosadler perspectivesonthecovid19pandemicimpactoncardiooncologyresultsfromthecovid19internationalcollaborativenetworksurvey AT jeannemdecara perspectivesonthecovid19pandemicimpactoncardiooncologyresultsfromthecovid19internationalcollaborativenetworksurvey AT joergherrmann perspectivesonthecovid19pandemicimpactoncardiooncologyresultsfromthecovid19internationalcollaborativenetworksurvey AT anitaarnold perspectivesonthecovid19pandemicimpactoncardiooncologyresultsfromthecovid19internationalcollaborativenetworksurvey AT arjunkghosh perspectivesonthecovid19pandemicimpactoncardiooncologyresultsfromthecovid19internationalcollaborativenetworksurvey AT husamabdelqadir perspectivesonthecovid19pandemicimpactoncardiooncologyresultsfromthecovid19internationalcollaborativenetworksurvey AT erichyang perspectivesonthecovid19pandemicimpactoncardiooncologyresultsfromthecovid19internationalcollaborativenetworksurvey AT sebastianszmit perspectivesonthecovid19pandemicimpactoncardiooncologyresultsfromthecovid19internationalcollaborativenetworksurvey AT nausheenakhter perspectivesonthecovid19pandemicimpactoncardiooncologyresultsfromthecovid19internationalcollaborativenetworksurvey AT monikaleja perspectivesonthecovid19pandemicimpactoncardiooncologyresultsfromthecovid19internationalcollaborativenetworksurvey AT carolinamariapintodominguescarvalhosilva perspectivesonthecovid19pandemicimpactoncardiooncologyresultsfromthecovid19internationalcollaborativenetworksurvey AT jayantraikhelkar perspectivesonthecovid19pandemicimpactoncardiooncologyresultsfromthecovid19internationalcollaborativenetworksurvey AT sherryannbrown perspectivesonthecovid19pandemicimpactoncardiooncologyresultsfromthecovid19internationalcollaborativenetworksurvey AT susandent perspectivesonthecovid19pandemicimpactoncardiooncologyresultsfromthecovid19internationalcollaborativenetworksurvey AT rupaloquinn perspectivesonthecovid19pandemicimpactoncardiooncologyresultsfromthecovid19internationalcollaborativenetworksurvey AT franckthuny perspectivesonthecovid19pandemicimpactoncardiooncologyresultsfromthecovid19internationalcollaborativenetworksurvey AT rohitmoudgil perspectivesonthecovid19pandemicimpactoncardiooncologyresultsfromthecovid19internationalcollaborativenetworksurvey AT luiseraez perspectivesonthecovid19pandemicimpactoncardiooncologyresultsfromthecovid19internationalcollaborativenetworksurvey AT tochukwuokwuosa perspectivesonthecovid19pandemicimpactoncardiooncologyresultsfromthecovid19internationalcollaborativenetworksurvey AT andresdaniele perspectivesonthecovid19pandemicimpactoncardiooncologyresultsfromthecovid19internationalcollaborativenetworksurvey AT brentonbauer perspectivesonthecovid19pandemicimpactoncardiooncologyresultsfromthecovid19internationalcollaborativenetworksurvey AT lavanyakondapalli perspectivesonthecovid19pandemicimpactoncardiooncologyresultsfromthecovid19internationalcollaborativenetworksurvey AT roohiismailkhan perspectivesonthecovid19pandemicimpactoncardiooncologyresultsfromthecovid19internationalcollaborativenetworksurvey AT jorgelax perspectivesonthecovid19pandemicimpactoncardiooncologyresultsfromthecovid19internationalcollaborativenetworksurvey AT anneblaes perspectivesonthecovid19pandemicimpactoncardiooncologyresultsfromthecovid19internationalcollaborativenetworksurvey AT zeinanahleh perspectivesonthecovid19pandemicimpactoncardiooncologyresultsfromthecovid19internationalcollaborativenetworksurvey AT leahelson perspectivesonthecovid19pandemicimpactoncardiooncologyresultsfromthecovid19internationalcollaborativenetworksurvey AT laurenabaldassarre perspectivesonthecovid19pandemicimpactoncardiooncologyresultsfromthecovid19internationalcollaborativenetworksurvey AT vladzaha perspectivesonthecovid19pandemicimpactoncardiooncologyresultsfromthecovid19internationalcollaborativenetworksurvey AT vijayrao perspectivesonthecovid19pandemicimpactoncardiooncologyresultsfromthecovid19internationalcollaborativenetworksurvey AT danielsierralara perspectivesonthecovid19pandemicimpactoncardiooncologyresultsfromthecovid19internationalcollaborativenetworksurvey AT kerryskurka perspectivesonthecovid19pandemicimpactoncardiooncologyresultsfromthecovid19internationalcollaborativenetworksurvey AT onbehalfofthecardiooncologyinternationalcollaborativenetwork perspectivesonthecovid19pandemicimpactoncardiooncologyresultsfromthecovid19internationalcollaborativenetworksurvey |
_version_ |
1724412100610097152 |